Paired molecular testing of amniotic fluid and fetal ventricular cerebrospinal fluid for Toxoplasma gondii and cytomegalovirus in severe fetal hydrocephalus: a descriptive case series
Abstract Background Severe fetal hydrocephalus has heterogeneous structural, genetic, hemorrhagic, and infectious causes. Amniotic-fluid molecular testing is established for suspected cytomegalovirus (CMV) and Toxoplasma gondii infection, whereas testing of fetal ventricular cerebrospinal fluid (CSF) obtained during cephalocentesis is rarely reported. Methods In this single-centre descriptive cross-sectional case series, nine pregnant women carrying fetuses with severe or progressive hydrocephalus underwent clinically indicated cephalocentesis at RSAB Harapan Kita, Jakarta, from March to July 2026. Paired amniotic-fluid and ventricular-CSF specimens underwent real-time PCR for T. gondii and CMV; maternal IgG, IgM, and IgG avidity were also assessed. Data were summarized descriptively, with exact binomial 95% confidence intervals for zero-detection proportions. Results Median maternal age was 31 years (26–36) and gestational age was 30.71 weeks (21.57–36.71). Neither pathogen was detected in amniotic fluid or ventricular CSF (0/9 for each pathogen in each compartment; exact 95% CI 0–33.6%). T. gondii IgG was positive in 5/9, IgM was negative in 9/9, and avidity was high in all five IgG-positive participants. CMV IgG was positive in 9/9, IgM was negative in 9/9, and avidity was high in 9/9. Median ventricular-CSF volume was 40 mL (30–50). Posterior ventricular width decreased from 35.35 to 25.61 mm immediately after aspiration (median decrease 8.21 mm, range 2.72–26.44), a descriptive anatomical observation. Delivery outcomes were available for seven pregnancies; all were live births by caesarean delivery, while two pregnancies remained ongoing. Conclusions In this small selected series, paired testing found no molecular evidence of T. gondii or CMV in either fetal compartment, and maternal serology did not support recent primary infection. A negative ventricular-CSF PCR should not be treated as a validated rule-out test. Prenatal infection testing should use amniotic fluid and be interpreted with maternal serology and fetal imaging; this series does not support cephalocentesis solely to detect infection.
Authors
- Damar Prasmusinto (ORCID: https://orcid.org/0000-0002-8613-2391)
- Mohammad Adya Firmansha Dilmy (ORCID: https://orcid.org/0000-0003-2972-3387)
- Yuditiya Purwosunu (ORCID: https://orcid.org/0000-0002-9882-8820)
- Noroyono Wibowo (ORCID: https://orcid.org/0000-0003-3995-6870)
- Yudianto Budi Saroyo (ORCID: https://orcid.org/0000-0002-9374-8178)
- Rima Irwinda (ORCID: https://orcid.org/0000-0002-6260-6273)
- Agustina Nurmala
- Gatot Abdurrazak
Institutions
- University of Indonesia (ID)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-16
- DOI
- https://doi.org/10.21203/rs.3.rs-11200217/v1
- Primary Topic
- Toxoplasma gondii Research Studies
- Type
- preprint